Hoberman Kenneth (CIK 1573722) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy NVCT (35,000 shares), Buy TGTX (14,718 shares), Buy NVCT (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Nuvectis Pharma, Inc. (NVCT) | Director | Buy | 35,000 | $0 |
| 2025-06-16 | TG THERAPEUTICS, INC. (TGTX) | Director | Buy | 14,718 | $0 |
| 2025-06-12 | Nuvectis Pharma, Inc. (NVCT) | Director | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12